Platelet Microparticle-Derived MiR-320b Inhibits Hypertension with Atherosclerosis Development by Targeting ETFA

Yongcong He1, Yangyang Jiang2, Fan Wu1

  • 1Department of Cardiology, Guangdong Second Provincial General Hospital.

PubMed

Insights

Platelet microparticle-derived microRNA-320b (miR-320b) plays a protective role in hypertension and atherosclerosis. Lower miR-320b levels in patients contribute to disease progression by targeting ETFA.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Biochemistry

Background:

  • Hypertension and atherosclerosis frequently coexist, presenting a complex clinical challenge.
  • Platelet microparticles (PMPs) are increasingly recognized as key mediators in cardiovascular disease.
  • The specific role of microRNA-320b (miR-320b) derived from PMPs in this dual pathology remains unclear.

Purpose of the Study:

  • To investigate the mechanism of PMP-derived miR-320b in patients with co-occurring hypertension and atherosclerosis.
  • To elucidate the regulatory role of miR-320b in endothelial cell function under hypoxic conditions.

Main Methods:

  • Sample collection from control subjects and patients with hypertension and atherosclerosis.
  • In vitro induction of PMPs and hypoxic human umbilical vein endothelial cells (HUVECs).
  • Quantitative real-time PCR (RT-qPCR), Western blotting, and various cell-based assays (MTT, EdU, wound healing) to assess gene/protein expression, cell viability, proliferation, migration, oxidative stress, and inflammation.

Main Results:

  • miR-320b expression was decreased in platelets and PMPs but elevated in plasma of affected patients.
  • miR-320b enhanced HUVEC viability, proliferation, and migration under hypoxic conditions.
  • miR-320b modulated oxidative stress and inflammatory markers, with beneficial effects observed when miR-320b levels were increased.
  • These effects were mediated by miR-320b targeting the ETFA gene.

Conclusions:

  • PMP-derived miR-320b acts as a protective factor against the development of hypertension complicated by atherosclerosis.
  • The inhibitory effect of miR-320b on disease progression is achieved through its regulation of ETFA and subsequent modulation of endothelial cell function, oxidative stress, and inflammation.